| Emerging approaches to overcome acquired drug resistance obstacles to osimertinib in non-small-cell lung cancer M Shaikh, Y Shinde, R Pawara, M Noolvi, S Surana, I Ahmad, H Patel Journal of medicinal chemistry 65 (2), 1008-1046, 2021 | 53 | 2021 |
| In silico search of triple mutant T790M/C797S allosteric inhibitors to conquer acquired resistance problem in non-small cell lung cancer (NSCLC): a combined … HM Patel, I Ahmad, R Pawara, M Shaikh, S Surana Journal of Biomolecular Structure and Dynamics 39 (4), 1491-1505, 2021 | 53 | 2021 |
| p38α MAP kinase inhibitors to overcome EGFR tertiary C797S point mutation associated with osimertinib in non-small cell lung cancer (NSCLC): emergence of fourth-generation EGFR … I Ahmad, M Shaikh, S Surana, A Ghosh, H Patel Journal of Biomolecular Structure and Dynamics 40 (7), 3046-3059, 2022 | 45 | 2022 |
| Synthesis, molecular modelling study of the methaqualone analogues as anti-convulsant agent with improved cognition activity and minimized neurotoxicity I Ahmad, SR Akand, M Shaikh, R Pawara, SN Manjula, H Patel Journal of Molecular Structure 1251, 131972, 2022 | 40 | 2022 |
| BREED based de novo hybridization approach: Generating novel T790M/C797S-EGFR tyrosine kinase inhibitors to overcome the problem of mutation and resistance in non small cell … HM Patel, M Shaikh, I Ahmad, D Lokwani, SJ Surana Journal of Biomolecular Structure and Dynamics 39 (8), 2838-2856, 2021 | 34 | 2021 |
| Graphene quantum dot based ultrasensitive probe for biosensing of prostate cancer biomarkers: current updates and future challenges J Pantwalawalkar, S Chandankar, R Tade, Z Khan, M Shaikh, T Powar, ... Advances in Natural Sciences: Nanoscience and Nanotechnology 13 (1), 013001, 2022 | 21 | 2022 |
| Extensively Drug-resistant Tuberculosis (XDR-TB)-inhibitors to overcome the scourge of drug-resistant tuberculosis: A perspective H Patel, I Ahmad, H Jadhav, R Pawara, A Mundada, M Shaikh, S Surana Reviews and Advances in Chemistry 10, 112-139, 2020 | 2 | 2020 |
| Structural toxicity relationship (STR) of linezolid to mitigate myelosuppression and serotonergic toxicity | | |
Harun M.Patel (Medicinal Chemist)Professor, Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical EducationVerifisert e-postadresse på rcpatelpharmacy.co.in